Evaluation of the Federal 340B Drug Pricing Program

Monday, June 11, 2018: 1:30 PM-3:00 PM
1000 - First Floor (Rollins School of Public Health)
Chair:
Jeah (Kyoungrae) Jung
1:30 PM
Consequences of the 340B Drug Pricing Program

Author(s): Sunita Desai; J. Michael McWilliams

Discussant: Abby Alpert

1:50 PM
A Prescription for Manipulation? Impact of the 340B Drug Discount Program on Hospitals

Author(s): Sayeh S. Nikpay; Melinda B. Buntin; Rena Conti

Discussant: David E. Tawes

2:10 PM
The Impact of a Federal Drug Pricing Program on Cancer Care Site and Spending in Medicare

Author(s): Jeah (Kyoungrae) Jung; Wendy Xu; Yamini Kalindindi

Discussant: Bingxiao Wu

See more of: Prescription Drugs